MedTrace Logo

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

NCT02508155 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2021-04-15

No results posted yet for this study

Summary

The purpose of this study is to assess the safety, drug levels and effects on the body of MEDI7352, in subjects with painful osteoarthritis of the knee.

Conditions

Interventions

BIOLOGICAL

MEDI7352 for IV infusion

MEDI7352 for IV infusion

BIOLOGICAL

Placebo for IV infusion

IV Placebo infusion

BIOLOGICAL

MEDI7352 for Subcutaneous Injection

MEDI7352 for subcutaneous injection

BIOLOGICAL

Placebo for Subcutaneous Injection

Subcutaneous Placebo Injection

Sponsors & Collaborators

Principal Investigators

  • David Bell, MB BCh BAO MRCGP FFPM · Biokinetics

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-17
Primary Completion
2020-12-23
Completion
2020-12-23

Countries

  • Germany
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02508155 on ClinicalTrials.gov